September 1 – November 30, 2026
We are not building a lab. For the first 90 days we borrow one. We hire a doctor to lead the science, pay an established lab to run the test, use local clinics to collect blood, and send samples out for deeper analysis. Everything else waits until we see a real signal.
Phase 1 · Days 1–30 · September 1–30
Ask an immune-system doctor whether these cells are different enough to be worth a special test.
List the other things that could raise the count — old infections, immune diseases, medicines — so we do not fool ourselves.
Ask a Phoenix university lab if they can repeat the published measurement.
Put a small group of expert advisers together before we spend money on equipment.
Phase 2 · Days 31–60 · October 1–31
Write down exactly how the test will be run, step by step, so the same blood gives the same answer twice.
Decide who can take part, and get approval from the independent ethics board that protects volunteers.
Use existing local clinics to find volunteers and draw blood, instead of building our own.
Arrange the deeper genetic analysis for later, if the first numbers look interesting.
Phase 3 · Days 61–90 · November 1–30
Measure a small group of volunteers of different ages, and check the test gives steady results.
See how much people differ from one another, and whether the striking cases really stand out.
Decide honestly whether this deserves a bigger study in 2027 — or whether it does not.
Only then even think about manufacturing or regulators.
Project Sponsor / Business Lead
Owns scope, funding, partnerships and go/no-go decisions. Keeps business claims separate from scientific conclusions.
Principal Investigator, MD
Clinical leadership, inclusion and exclusion criteria, participant safety, IRB submission and interpretation of immune findings.
T-Cell Immunology Scientific Lead
Pressure-tests the biology, defines the cytotoxic CD4 phenotype and advises on markers, controls and confounders.
Flow Cytometry Assay Development Lead
Builds and validates the research panel. Obtained through a partner core facility rather than hired full-time.
Sequencing & Bioinformatics Support
T-cell receptor repertoire analysis and clonality interpretation.
Regulatory & Ethics Adviser
IRB pathway, consent, data handling and the line between research and clinical claims.